Vertebroplasty for acute painful osteoporotic fractures (VAPOUR): study protocol for a randomized controlled trial

William Clark, Paul Bird, Terrence Diamond, Peter Gonski, William Clark, Paul Bird, Terrence Diamond, Peter Gonski

Abstract

Background: With increasing human longevity there is increasing prevalence of osteoporosis and of osteoporotic vertebral fractures. Most vertebral fractures do not require medical therapy for pain, but a minority are associated with severe pain and disability. Vertebroplasty has been used increasingly for painful acute osteoporotic fractures. The best available evidence for vertebroplasty is provided by two placebo controlled trials which showed no significant clinical benefit of vertebroplasty over placebo. These were not acute fracture trials with the majority of fractures in both trials being well beyond the acute time frame of 6 weeks. There is evidence from an open label randomized controlled trial of vertebroplasty versus conservative therapy in acute fractures suggesting clinical efficacy in acute vertebral fractures.

Methods: This is a blinded trial of Vertebroplasty for Acute Painful Osteoporotic fractURes - the VAPOUR trial. Patients greater than 60 years in age with new severe onset of back pain and osteoporotic vertebral fractures of less than 6 weeks duration will be enrolled. They will be randomized to receive either vertebroplasty or a placebo procedure. Data regarding pain, disability, and quality of life will be collected over a 6-month period. The enrolled patients and the outcome assessors will remain blinded for the duration of the trial.

Discussion: The VAPOUR trial will apply similar methodology to the previous blinded trials but in a patient group with exclusively acute fractures and the most severe pain.

Trial registration: ClinicalTrials.gov trial identifier: NCT01482793 registered on 28 November 2011.

References

    1. Kallmes DF, Comstock BA, Heagerty PJ, Turner JA, Wilson DJ, Diamond TH, et al. A randomized trial of vertebroplasty for osteoporotic spinal fractures. N Engl J Med. 2009;361(6):569–79. doi: 10.1056/NEJMoa0900563.
    1. Buchbinder R, Osborne RH, Ebeling PR, Wark JD, Mitchell P, Wriedt C, et al. A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures. N Engl J Med. 2009;361(6):557–68. doi: 10.1056/NEJMoa0900429.
    1. Klazen CA, Lohle PN, de Vries J, Jansen FH, Tielbeek AV, Blonk MC, et al. Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (Vertos II): an open-label randomised trial. Lancet. 2010;376:1085–92. doi: 10.1016/S0140-6736(10)60954-3.
    1. Wardlaw D, Cummings SR, Van Meirhaeghe J, Bastian L, Tillman JB, Ranstam J, et al. Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial. Lancet. 2009;373(9668):1016–24. doi: 10.1016/S0140-6736(09)60010-6.
    1. Gangi A, Clark WA. Have recent vertebroplasty trials changed the indications for vertebroplasty? Cardiovasc Intervent Radiol. 2010;33(4):677–80. doi: 10.1007/s00270-010-9901-3.
    1. Clark WA, Diamond TH, McNeil HP, Gonski PN, Schlaphoff GP, Rouse JC. Vertebroplasty for painful acute osteoporotic vertebral fractures: recent Medical Journal of Australia editorial is not relevant to the patient group that we treat with vertebroplasty. Med J Aust. 2010;192(6):334–7.
    1. Boszczyk B. Volume matters: A review of procedural details of two controlled vertebroplasty trials of 2009. Eur Spine J. 2010;19:1837–40. doi: 10.1007/s00586-010-1525-4.
    1. Robinson Y, Olerud C. Vertebroplasty and kyphoplasty - a systematic review of cement augmentation techniques for osteoporotic vertebral compression fractures compared to standard medical therapy. Maturitas. 2012;72(1):42–9. doi: 10.1016/j.maturitas.2012.02.010.
    1. Johnson J, Rogers W, Jeffree RL. The controversy over vertebroplasty: an analysis of the debate and proposals for a way forward. J Med Imaging Radiat Oncol. 2012;56(4):449–51. doi: 10.1111/j.1754-9485.2012.02409.x.
    1. McCullough BJ, Comstock BA, Deyo RA, Kreuter W, Jarvik JG. Major medical outcomes with spinal augmentation vs conservative therapy. JAMA Int Med. 2013;173(16):1514–21. doi: 10.1001/jamainternmed.2013.8725.
    1. Staples MP, Kallmes DF, Comstock BA, Jarvik JG, Osborne RH, Heagerty PJ, et al. Effectiveness of vertebroplasty using individual patient data from two randomised placebo controlled trials: meta-analysis. BMJ. 2011;343:3952. doi: 10.1136/bmj.d3952.
    1. Yu CW, Hsu CY, Shih TT, Chen BB, Fu CJ. Vertebral osteonecrosis: MR imaging findings and related changes on adjacent levels. AJNR Am J Neuroradiol. 2007;28(1):42–7.
    1. Lane JI, Maus TP, Wald JT, Thielen KR, Bobra S, Luetmer PH. Intravertebral clefts opacified during vertebroplasty: pathogenesis, technical implications, and prognostic significance. AJNR Am J Neuroradiol. 2002;23:1642–6.
    1. McKiernan F, Faciszewski T. Intravertebral clefts in osteoporotic vertebral compression fractures. Arthritis & Rheumatism. 2003;48:1414–9. doi: 10.1002/art.10984.
    1. McKiernan F, Jensen R, Faciszewski T. The dynamic mobility of vertebral compression fractures. J Bone Miner Res. 2003;18:24–9. doi: 10.1359/jbmr.2003.18.1.24.
    1. Gray LA, Jarvik JG, Heagerty PJ, Hollingworth W, Stout L, Comstock BA, et al. Investigational Vertebroplasty Efficacy and Safety Trial (INVEST): a randomized controlled trial of percutaneous vertebroplasty. BMC Musculoskelt Disord. 2007;8:126. doi: 10.1186/1471-2474-8-126.
    1. Trout AT, Kallmes DF, Gray LA, Goodnature BA, Everson SL, Comstock BA, et al. Evaluation of vertebroplasty with a validated outcome measure: the Roland-Morris Disability Questionnaire. AJNR Am J Neuroradiol. 2005;26(10):2652–7.
    1. Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O, et al. Quality of life in patients with vertebral fractures: Validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO) Osteoporosis Int. 1999;10:150–60. doi: 10.1007/s001980050210.
    1. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol group. Ann Med. 2001;33(5):337–43. doi: 10.3109/07853890109002087.
    1. Australian Medicines Handbook (online). Australian Medicines Handbook Pty Ltd. 2015. . Accessed 27 Feb 2015.
    1. Faculty of Pain Medicine. Opioid Dose Equivalence: calculation of oral Morphine Equivalent Daily Dose (oMEDD). Australian and New Zealand College of Anaesthetists. . Accessed 2 March 2015
    1. Podsiadlo D, Richardson S. The timed “Up and Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 1991;39(2):142–8.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj